# Minocyclin in Ulcerative Colitis as Added on Therapy

> **NCT06201793** · PHASE2 · COMPLETED · sponsor: **Mostafa Bahaa** · enrollment: 46 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Mesalazine
- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT06201793
- **Lead sponsor:** Mostafa Bahaa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-22
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06201793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06201793, "Minocyclin in Ulcerative Colitis as Added on Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06201793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*